Nitazoxanide

规格

55981-09-4CAS 号

259-931-8EC 号

[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetateIUPAC 名称

C12H9N3O5S化学式

307.28 g/mol分子量

NITAZOXANIDE; 55981-09-4; Alinia; Nitazoxanida; Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-; Nitazoxanidum; 2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate; 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide; DTXSID5033757; NSC697855; NSC-697855; NSC-760057; PH 5776; PH-5776; SOA12P041N; Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester); DTXCID3013757; 2-((5-nitro-1,3-thiazol-2-yl)carbamoyl)phenyl acetate; RefChem:55715; P01AX11; Salicylamide, N-(5-nitro-2-thiazolyl)-, Acetate(Ester); 2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate; Nitazoxamide; Nitazoxanid; Daxon; Nitazoxanidum [INN-Latin]; Nitazoxanida [INN-Spanish]; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide; [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate; C12H9N3O5S; Nitrazoxanide; MFCD00416599; NTZ; 2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide; N-(5-Nitrothiazol-2-yl)salicylamide acetate ester; [2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate; MMV688991; o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate; NCGC00090774-01; Colufase; Cryptaz; Heliton; Phavic-1; O-[N-(5-nitrothiazol-2-yl)carbamoyl]phenyl acetate; SMR000466367; NSC 697855; Alinia (TN); CAS-55981-09-4; S1627; 2-[(5-Nitrothiazol-2-yl)carbamoyl]phenyl Acetate; EINECS 259-931-8; Nitazoxanide (USAN/INN); (2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat; BRN 1225475; UNII-SOA12P041N; N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester); Pacovanton; Dexidex; Kidonax; Nitazox; Paramix; Nitax; Toza; Nitazoxanide [USAN:INN:BAN]; YQNQNVDNTFHQSW-UHFFFAOYSA-N; Alinia(TM); CPD000466367; Nitazoxanide (Standard); NITAZOXANIDE [MI]; NITAZOXANIDE [INN]; NCIMech_000843; NITAZOXANIDE [USAN]; CHEMBL1401; NITAZOXANIDE [VANDF]; Oprea1_263587; SCHEMBL40981; NITAZOXANIDE [MART.]; MLS000759492; MLS001424074; MLS006010127; NITAZOXANIDE [USP-RS]; NITAZOXANIDE [WHO-DD]; Nitazoxanide (Alinia, Annita); orb1308235; Nitazoxanide (Alinia, Annita)?; SCHEMBL29373905; CHEBI:94807; HY-B0217R; Nitazoxanide - Bio-X trade mark; NITAZOXANIDE [GREEN BOOK]; Nitazoxanide, >=98% (HPLC); NTZ;NSC 697855; GLXC-05393; HMS2051L04; HMS3393L04; HMS3655M11; HMS3715F10; HMS5079I22; NITAZOXANIDE [ORANGE BOOK]; Pharmakon1600-01503843; HY-B0217; Tox21_111018; Tox21_201226; BDBM50075050; CCG-35851; EBC-06082; MSK156811; NSC760057; AKOS015915393; Tox21_111018_1; AC-1302; DB00507; FN26229; KS-1160; NC00246; NCGC00090774-02; NCGC00090774-03; NCGC00090774-04; NCGC00090774-05; NCGC00258778-01; BN164151; NCI60_034935; SY108901; Nitrazoxanide 100 |Ig/mL in Acetonitrile; N1031; Nitrazoxanide 100 microg/mL in Acetonitrile; NS00033434; ST51059722; SW197626-2; D02486; EN300-220095; AB00639988-07; AB00639988-09; AB00639988_10; AB00639988_11; F076695; SR-01000759418; Q2943789; SR-01000759418-9; BRD-K96471533-001-07-4; BRD-K96471533-001-08-2; BRD-K96471533-001-09-0; BRD-K96471533-001-10-8; NTZ; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide; Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester); Z1514087129; 2-[N-(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate; Nitazoxanide, United States Pharmacopeia (USP) Reference Standard; acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester; Zox同义词